EyePoint Pharmaceuticals ... (EYPT)
NASDAQ: EYPT
· Real-Time Price · USD
11.09
0.24 (2.21%)
At close: Aug 15, 2025, 3:59 PM
11.09
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT
EyePoint Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 71.14M | 85.16M | 99.7M | 79.83M | 90.77M | 271.01M | 281.26M | 133.03M | 139.6M | 105.77M | 95.63M | 75.36M | 82.13M | 101.55M | 178.59M | 119.71M | 127.63M | 138.58M |
Short-Term Investments | 184.59M | 233.04M | 271.21M | 173.96M | 189.48M | 28.34M | 49.79M | 2.98M | 2.94M | 16.72M | 48.93M | 81.9M | 89.03M | 89.24M | 32.97M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K |
Other Long-Term Assets | 14.81M | 6.03M | 5.98M | 2.57M | n/a | n/a | n/a | 4.48M | 2.87M | 2.61M | 1.36M | 1.17M | n/a | 150K | 626K | 710K | 150K | 150K |
Receivables | 625K | 442K | 607K | 378K | 1.38M | 3.02M | 805K | 483K | 10.95M | 10.42M | 15.5M | 20.88M | 22.59M | 19.59M | 18.35M | 13.6M | 15.11M | 12.33M |
Inventory | 2.68M | 2.13M | 2.31M | 2.81M | 3.67M | 4.26M | 3.91M | 4.58M | 4.26M | 4.07M | 2.89M | 3.53M | 3.25M | 3.34M | 3.62M | 4.57M | 5.38M | 5.59M |
Other Current Assets | 6.21M | 1.4M | 1.41M | 11.57M | 1.06M | 1.48M | 1.01M | 9.09M | 9.37M | 9.08M | 9.86M | 10.44M | 8.85M | 5.92M | 4.22M | 3.89M | 3.7M | 2.86M |
Total Current Assets | 265.25M | 326.98M | 383.31M | 268.55M | 294.93M | 317.71M | 344.8M | 150.16M | 167.12M | 146.06M | 172.81M | 192.1M | 205.87M | 219.63M | 237.75M | 141.78M | 151.83M | 159.35M |
Property-Plant & Equipment | 21.09M | 29.55M | 29.18M | 29.8M | 29.17M | 11.39M | 10.23M | 5.25M | 5.51M | 5.78M | 6.04M | 6.32M | 5.9M | 2.64M | 2.25M | 2.4M | 2.87M | 3.04M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.9M | 21.52M | 22.13M | 22.75M | 23.36M | 23.98M | 24.59M |
Total Long-Term Assets | 35.9M | 35.58M | 35.16M | 32.37M | 29.32M | 11.54M | 10.38M | 9.88M | 8.54M | 8.54M | 7.55M | 28.39M | 27.57M | 24.93M | 25.63M | 26.48M | 27M | 27.79M |
Total Assets | 301.15M | 362.56M | 418.46M | 300.92M | 324.25M | 329.25M | 355.18M | 160.04M | 175.66M | 154.59M | 180.36M | 220.49M | 233.43M | 244.56M | 263.37M | 168.25M | 178.82M | 187.14M |
Account Payables | 31.16M | 16.42M | 11.72M | 7.34M | 14.3M | 7.08M | 6.5M | 9.58M | 10.72M | 9.45M | 5.92M | 6.11M | 7.06M | 7.3M | 7.38M | 6.64M | 5.42M | 5.86M |
Deferred Revenue | n/a | 5.12M | 17.78M | 26M | 33.34M | 38.38M | 38.59M | 39.84M | 42.08M | 1.24M | 1.21M | 1.17M | 1.14M | 1.1M | 1.07M | 1.03M | 1.01M | 973K |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.29M | 10.47M | 10.47M | 10.47M | 10.47M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 2.01M | 5.59M | 13.27M | 15.46M | 6.35M | 11.62M | 5.54M | 4.95M | 8.88M | 6.75M | 6.09M | 8.1M | 8M | 8.46M | 5.58M | 6.28M | 6.36M | 3.03M |
Total Current Liabilities | 33.17M | 41.68M | 49.05M | 48.79M | 62.1M | 62.58M | 63.26M | 63.9M | 68.92M | 27.24M | 34.54M | 34.26M | 33.39M | 31.97M | 23.66M | 19.93M | 16.25M | 13.44M |
Long-Term Debt | n/a | n/a | n/a | 21.92M | n/a | n/a | n/a | n/a | n/a | 29.37M | 29.31M | 29.25M | 29.18M | 29.11M | 36.56M | 36.4M | 36.23M | 38.12M |
Other Long-Term Liabilities | 148K | 177K | 205K | 11.47M | n/a | n/a | n/a | n/a | n/a | 600K | 600K | 600K | 600K | 658K | 2.35M | 2.36M | 2.33M | 2.35M |
Total Long-Term Liabilities | 21.96M | 22.49M | 32.92M | 33.39M | 33.84M | 16.73M | 25.6M | 37.53M | 49.48M | 48.96M | 49.45M | 49.88M | 48.68M | 45.77M | 55.33M | 55.57M | 55.71M | 57.99M |
Total Liabilities | 55.14M | 64.17M | 81.96M | 82.18M | 95.94M | 79.31M | 88.86M | 101.42M | 118.39M | 76.2M | 83.99M | 84.14M | 82.07M | 77.74M | 78.99M | 75.5M | 71.96M | 71.43M |
Total Debt | 21.82M | 24.08M | 21.86M | 21.92M | 23.29M | 5.72M | 5.47M | 5.18M | 5.46M | 40.39M | 45.77M | 45.96M | 44.48M | 41.28M | 38.42M | 38.41M | 38.25M | 40.3M |
Common Stock | 1.22B | 69K | 68K | 53K | 52K | 50K | 49K | 785.83M | 771.86M | 770.06M | 766.93M | 763.6M | 34K | 34K | 752.64M | 641.57M | 29K | 29K |
Retained Earnings | -977.64M | -918.21M | -873.02M | -831.62M | -802.26M | -771.43M | -742.15M | -728.05M | -715.43M | -692.51M | -671.35M | -627.9M | -609.48M | -590.07M | -569.1M | -549.66M | -532.97M | -522.96M |
Comprehensive Income | 832K | 923K | 1.03M | 1.17M | 792K | 836K | 864K | 841K | 842K | 843K | 786K | 653K | 602K | 788K | 841K | 841K | 841K | 841K |
Shareholders Equity | 246.01M | 298.4M | 336.5M | 218.73M | 228.31M | 249.93M | 266.32M | 58.62M | 57.26M | 78.39M | 96.37M | 136.35M | 151.37M | 166.82M | 184.38M | 92.75M | 106.86M | 115.71M |
Total Investments | 184.59M | 233.04M | 271.21M | 173.96M | 189.63M | 28.48M | 49.94M | 2.98M | 2.94M | 16.72M | 48.93M | 81.9M | 89.03M | 89.24M | 32.97M | 150K | 150K | 150K |